Some users are taking on debt or cutting contributions to stay on the drugs, and those not fully covered pay about $203 a month out of pocket.
Recap by typeshit. Full story at 401k Specialist.
Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
Avi Roy puts last year's sales of the two shots at $71B, roughly four times the $18B he says the two AI labs brought in.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
TCTMD covers new data on two next-generation drugs, retatrutide and survodutide, for weight loss in diabetic patients. Tap through for the trial details.
Researchers tested the combination in vivo and report lower peripheral immune activation and fewer inflammatory gene signatures in the central nervous system.
Loading…